EW
What one share of Edwards Lifesciences holds
Orthopedic, Prosthetic and Surgical Appliances and Supplies
Edwards Lifesciences Corporation is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence, and meaningful partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most.
Edwards Lifesciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $11.20 |
|---|---|
| Profit | $1.73 |
| Capex (buildings and equipment) | $0.49 |
| Free cash flow | $2.47 |
| Cash and investments | $5.04 |
| Debt | $1.04 |
| Book value | $18.41 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $4.54 | $0.87 | $0.27 | $0.81 | — | $4.13 |
| 2017 | $5.30 | $0.90 | $0.26 | $1.29 | — | $4.70 |
| 2018 | $5.81 | $1.13 | $0.37 | $1.07 | — | $5.04 |
| 2019 | $6.83 | $1.64 | $0.40 | $1.46 | — | — |
| 2020 | $6.94 | $1.30 | $0.64 | $1.02 | — | $7.33 |
| 2021 | $8.29 | $2.38 | $0.52 | $2.23 | — | $9.35 |
| 2022 | $7.15 | $2.44 | $0.39 | $1.56 | — | $9.55 |
| 2023 | $8.22 | $2.30 | $0.42 | $1.05 | — | $11.06 |
| 2024 | $9.08 | $6.97 | $0.42 | $0.48 | — | $16.99 |
| 2025 | $10.36 | $1.83 | $0.44 | $2.28 | — | $17.80 |